Get the Stockscreener App
4.65
6.81%
-0.34
After Hours:
4.85
0.20
+4.30%
Dogwood Therapeutics Inc stock is traded at $4.65, with a volume of 27,757.
It is down -6.81% in the last 24 hours and down -2.52% over the past month.
Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its product candidates include IMC-1 and IMC-2. IMC-1 is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.
See More
Previous Close:
$4.99
Open:
$4.9889
24h Volume:
27,757
Relative Volume:
0.91
Market Cap:
$8.89M
Revenue:
-
Net Income/Loss:
$-5.73M
P/E Ratio:
-0.7099
EPS:
-6.55
Net Cash Flow:
$-4.13M
1W Performance:
-4.32%
1M Performance:
-2.52%
6M Performance:
-1.27%
1Y Performance:
+0.00%
1-Day Range:
$4.61
$4.99
1-Week Range:
$4.61
$5.2103
52-Week Range:
$1.62
$29.28
Dogwood Therapeutics Inc Stock (DWTX) Company Profile
Name
Dogwood Therapeutics Inc
Sector
Industry
Phone
(866) 620-8655
Address
44 MILTON AVENUE, ALPHARETTA
Compare DWTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DWTX
Dogwood Therapeutics Inc
|
4.65 | 9.54M | 0 | -5.73M | -4.13M | -6.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Dogwood Therapeutics Inc Stock (DWTX) Latest News
Dogwood Therapeutics Inc. stock trend outlook and recovery path2025 Geopolitical Influence & Low Risk High Reward Ideas - Newser
Visual analytics tools that track Dogwood Therapeutics Inc. performanceJuly 2025 Summary & Comprehensive Market Scan Reports - Newser
Can Dogwood Therapeutics Inc. disrupt its industry2025 Investor Takeaways & AI Powered Buy/Sell Recommendations - sundaytimes.kr
Signal strength of Dogwood Therapeutics Inc. stock in tech scanners2025 Bull vs Bear & Short-Term Trading Alerts - Newser
Can volume confirm reversal in Dogwood Therapeutics Inc.Market Movement Recap & AI Forecasted Entry and Exit Points - Newser
Combining price and volume data for Dogwood Therapeutics Inc.Market Trend Summary & Daily Momentum Trading Reports - Newser
Real time breakdown of Dogwood Therapeutics Inc. stock performanceShort Setup & Weekly High Conviction Trade Ideas - Newser
Advanced analytics toolkit walkthrough for Dogwood Therapeutics Inc.Weekly Gains Report & Weekly Watchlist for Hot Stocks - Newser
Applying Wyckoff theory to Dogwood Therapeutics Inc. stockEarnings Performance Report & AI Driven Stock Movement Reports - Newser
Sector ETF performance correlation with Dogwood Therapeutics Inc.2025 Stock Rankings & Long-Term Investment Growth Plans - Newser
What MACD and RSI say about Dogwood Therapeutics Inc.Long Setup & Technical Entry and Exit Alerts - Newser
Using AI based signals to follow Dogwood Therapeutics Inc.Market Growth Review & High Conviction Investment Ideas - Newser
Is it too late to sell Dogwood Therapeutics Inc.Weekly Trade Review & Real-Time Volume Analysis - Newser
News impact scoring models applied to Dogwood Therapeutics Inc.2025 Breakouts & Breakdowns & Consistent Profit Alerts - Newser
Leading vs lagging indicators on Dogwood Therapeutics Inc. performanceJuly 2025 Action & AI Enhanced Trading Signals - Newser
Dogwood Therapeutics Inc. stock daily chart insightsInflation Watch & Low Volatility Stock Recommendations - Newser
Published on: 2025-08-25 02:13:37 - Newser
What does recent volatility data suggest for Dogwood Therapeutics Inc.Oil Prices & Daily Momentum Trading Reports - Newser
Does Dogwood Therapeutics Inc. have consistent dividend growth2025 Major Catalysts & Technical Buy Zone Confirmations - theviewers.co.kr
Rate Cut: Can Dogwood Therapeutics Inc. disrupt its industryRate Hike & Weekly Momentum Stock Picks - theviewers.co.kr
Dogwood Therapeutics Inc. Hits Oversold Level on RSI Indicator2025 Earnings Impact & AI Forecasted Stock Moves - newsyoung.net
Fundamentals Check: Will Dogwood Therapeutics Inc. benefit from geopolitical trendsJuly 2025 Pullbacks & Comprehensive Market Scan Insights - sundaytimes.kr
How sensitive is Dogwood Therapeutics Inc. to inflationJuly 2025 Technicals & Free Weekly Watchlist of Top Performers - theviewers.co.kr
Is Dogwood Therapeutics Inc. stock heavily shortedWeekly Investment Summary & Long-Term Growth Stock Strategies - theviewers.co.kr
Dogwood Therapeutics Inc. Recovery Likely Here’s What Data ShowsJuly 2025 WrapUp & Risk Controlled Daily Trade Plans - 더경남뉴스
Can swing trading help recover from Dogwood Therapeutics Inc. lossesSell Signal & Technical Pattern Recognition Alerts - Newser
Sentiment analysis tools applied to Dogwood Therapeutics Inc.July 2025 Market Mood & Safe Entry Trade Reports - Newser
DWTX: Over 50 Patients Enrolled Thus Far in Phase 2b Halneuron® Trial; Interim Read Out in 4Q25 - Yahoo Finance
Does Dogwood Therapeutics Inc. show high probability of reboundWeekly Trend Summary & High Accuracy Trade Signal Alerts - Newser
Dogwood Therapeutics Inc Stock (DWTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
8.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):